Top Markets
Coin of the day
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
Rang în acțiuni #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
Preț acțiune
$2.70
Ultima sincronizare: 2023-05-17
Capitalizare de piață
$4.13M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Graybug Vision, Inc. (GRAY)

Categorie

Istoric al prețului acțiunii pentru Graybug Vision, Inc. (GRAY)
Cel mai mare preț de închidere: $3.07 pe 2023-05-01

Cel mai mic preț de închidere: $208.50 pe 2020-09-01
Istoric al prețului acțiunii pentru Graybug Vision, Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2023 -59.99%
2022 -72.75%
2021 -92.01%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE